Purpose: To report the endovascular repair of an aortobronchial fistula at the distal anastomosis of a complex thoracic graft.
Case Report: A 61-year-old man operated 18 years prior for aortic coarctation presented with hemoptysis. An aortobronchial fistula was suspected, but spiral computed tomography and angiography showed only a small pseudoaneurysm at the distal anastomosis without revealing the fistulous tract. A Talent stent-graft was successfully deployed through a femoral access, but the large delivery system injured the external iliac artery, producing a retroperitoneal hemorrhage. Prompt balloon occlusion of the aorta and subsequent bypass graft repair of the arterial injury prevented serious sequelae. The patient recovered without further complications. Follow-up imaging to 2 years has documented exclusion of the pseudoaneurysm with no hemoptysis or signs of new false aneurysm formation.
Conclusions: Endovascular exclusion of anastomotic pseudoaneurysms even in complicated cases can be an efficient treatment option, but the procedure must be carefully planned and executed in order to achieve good results.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/152660280100800412 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Current trends and evidence on post-TEVAR aorto-pulmonary and -bronchial fistula: a narrative review.
Ann Vasc Surg
January 2025
Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address:
Introduction: Aorto-bronchial or aorto-pulmonary fistulas (ABPF) are a rare but life-threatening complication following thoracic endovascular aortic repair (TEVAR). This narrative review aims to provide an overview of the current trends and available evidence on ABPF following TEVAR, evaluating risk factors, diagnostic approaches, and possible preventive and therapeutic strategies.
Methods: Relevant publications on post-TEVAR ABPF were selected through a literature search on PubMed.
The Publisher regrets that this article is an accidental duplication of an article that has already been published https://doi.org/10.1016/j.
View Article and Find Full Text PDFThoracic endovascular aortic repair (TEVAR) explantation and left lower lobectomy for aortobronchial fistula repair.
JTCVS Tech
October 2024
Department of Cardiothoracic Surgery, Emory University Hospitals, Atlanta, Ga.
Outcomes of Endovascular Treatment for Infectious Thoracic Aortic Diseases.
J Vasc Interv Radiol
January 2025
Department of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Purpose: To investigate the effectiveness and safety of thoracic endovascular aortic repair (TEVAR) for infectious aortic diseases.
Materials And Methods: Patients who underwent TEVAR for infectious aortic diseases including infected thoracic aortic aneurysm, aortobronchial fistula (ABF), and aortoenteric fistula from December 2011 to October 2022 at 4 institutions were retrospectively studied. The primary outcome of the study was overall survival, whereas the secondary outcome was comprehensive adverse events.
Cause of death for heart transplant patients, an autopsy study.
Cardiovasc Pathol
November 2024
Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. Electronic address:
Article Synopsis
- Heart transplantations are critical for patients with severe heart failure, but understanding complications and causes of death post-transplant is essential for improving patient care.
- A comprehensive review of autopsies from 1990 to 2023 revealed demographic data, clinical histories, and causes of death in 88 heart transplant patients.
- The study identified significant findings, including that 41.1% of deaths were related to the transplant operation, while 58.9% were due to other factors, with some unexpected causes not recognized before death.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!